PARP1 and head and neck squamous cell carcinoma: The investigators aim to demonstrate a significant prevalence of DDR gene mutations in the genomic landscape of HNSCC which may assist in laying groundwork for NGS-guided investigations of PARP inhibitors in HNSCC.